𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome

✍ Scribed by Morgane Stum; Claire-Sophie Davoine; Savine Vicart; Léna Guillot-Noël; Haluk Topaloglu; Francisco Javier Carod-Artal; Hülya Kayserili; Fayçal Hentati; Luciano Merlini; Jon Andoni Urtizberea; EL-Hadi Hammouda; Phuc Canh Quan; Bertrand Fontaine; Sophie Nicole

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
507 KB
Volume
27
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Communicated by Christine Van Broeckhoven

Schwartz-Jampel syndrome (SJS) is a rare autosomal recessive condition defined by the association of myotonia with chondrodysplasia. SJS results from mutations in the HSPG2 gene, which encodes perlecan, a major component of basement membranes. Only eight HSPG2 mutations have been reported in six SJS families. Here, we describe the molecular findings in 23 families (35 patients) with SJS, being one-third of the SJS cases reported in the medical literature. We identified 22 new HSPG2 mutations and unreported polymorphisms. Mutations included nine deletion or insertion (41%), six splice site (27%), five missense (23%), and two nonsense mutations (9%). All but four mutations were private, and we found no evidence for a founder effect. Analyses of HSPG2 messenger RNA (mRNA) and perlecan immunostaining on patients' cells revealed a hypomorphic effect of the studied mutations. They also demonstrated distinct consequences of truncating and missense mutations on perlecan expression as truncating mutations resulted in instability of HSPG2 mRNA through nonsense mRNA-mediated decay, whereas missense mutations involving cysteine residues led to intracellular retention of perlecan, probably due to quality control pathways. Our analyses strengthen the idea that SJS results from hypomorphic mutations of the HSPG2 gene. They also propose tools for its molecular diagnosis and provide new clues for the understanding of its pathophysiology. Hum Mutat 27(11),

📜 SIMILAR VOLUMES

MLL2 mutation spectrum in 45 patients wi
MLL2 mutation spectrum in 45 patients with Kabuki syndrome
✍ Aimée D. C. Paulussen; Alexander P. A. Stegmann; Marinus J. Blok; Demis Tserpeli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Kabuki Syndrome (KS) is a rare syndrome characterized by intellectual disability and multiple congenital abnormalities, in particular a distinct dysmorphic facial appearance. KS is caused by mutations in the MLL2 gene, encoding an H3K4 histone methyl transferase which acts as an epigenetic transcrip

Spectrum of PEX6 mutations in Zellweger
Spectrum of PEX6 mutations in Zellweger syndrome spectrum patients
✍ Merel S. Ebberink; Janet Kofster; Ronald J.A. Wanders; Hans R. Waterham 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

The autosomal recessive Zellweger syndrome spectrum (ZSS) disorders comprise a main subgroup of the peroxisome biogenesis disorders. The ZSS disorders can be caused by mutations in any of 12 different currently identified PEX genes resulting in severe, often lethal, multi-systemic disorders. Defects

Spectrum of USH2A mutations in Scandinav
Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II
✍ Bo Dreyer; Vigdis Brox; Lisbeth Tranebjærg; Thomas Rosenberg; Andrè M. Sadeghi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Communicated by Andreas Gal Usher syndrome type II (USH2) is an autosomal recessive disorder, characterised by moderate to severe high-frequency hearing impairment, normal balance function and progressive visual impairment due to retinitis pigmentosa. Usher syndrome type IIa, the most common su

Spectrum of COL4A5 mutations in Finnish
Spectrum of COL4A5 mutations in Finnish Alport syndrome patients
✍ Paula Martin; Niina Heiskari; Heli Pajari; Carola Grönhagen-Riska; Helena Kääriä 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

Alport syndrome (AS) is a hereditary kidney disorder, mainly caused by mutations in the Xchromosomal gene (COL4A5) encoding the type IV collagen α α5 chain. In this study, detection of COL4A5 mutations was performed in 17 Finnish Alport syndrome families. Regions around the 51 previously known exons

The spectrum of WRN mutations in Werner
The spectrum of WRN mutations in Werner syndrome patients
✍ Shurong Huang; Lin Lee; Nancy B. Hanson; Catherine Lenaerts; Holger Hoehn; Marti 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 1 views

The International Registry of Werner syndrome (www.wernersyndrome.org) has been providing molecular diagnosis of the Werner syndrome (WS) for the past decade. The present communication summarizes, from among 99 WS subjects, the spectrum of 50 distinct mutations discovered by our group and by others

Spectrum of mutations and sequence varia
Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome
✍ Anna Sillén; Ingrun Anton-Lamprecht; Cordula Braun-Quentin; Cornelia S. Kraus; B 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 2 views

The gene encoding the human fatty aldehyde dehydrogenase (FALDH) is located on 17p11.2, causing Sjögren-Larsson syndrome (SLS) when mutated. SLS is an autosomal recessive disorder characterized by a combination of mental retardation, congenital ichthyosis, and spastic di-or tetraplegia. We report he